Yustein Lab

MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma: buff.ly/43jlpbe @YusteinLab @EmoryMedicine #Oncology

I was honored to present the 2023 AACR-St Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research to Olivier Delattre.

@ATLPedsHemOnc @WinshipAtEmory @childrensatl @AgentsMIB Thank you!

Congratulations to Dr. Jason Yustein (@YusteinLab) with @WinshipAtEmory and @childrensatl for his $100,000 research grant through @AgentsMIB to study pediatric osteosarcoma

New Research: Single-cell RNA datasets and bulk RNA datasets analysis demonstrated C1Q+ tumor-associated macrophage as a major and antitumor immune cell population in osteosarcoma: Background Osteosarcoma is the most frequent primary bone… frontiersin.org/articles/10.33… #immunology

Here we are: @fede_giordano89 and @GENETICA75 made this happened, together with the support of a lot of others folks (cannot tag all) in collaboration with @YusteinLab cancer-nano.biomedcentral.com/articles/10.11…

Winship investigator Jason Yustein, MD, PhD, will receive a grant from the Osteosarcoma Institute (@OSInstitute) in support of his research using combination therapies to improve immune-mediated approaches for high-risk osteosarcoma. ➡️ fal.cn/3u36t

During this year's #BoneCancerAwarenessWeek we held our third annual Ewing sarcoma research meeting 🔬🧬 Together with @CwC_UK we brought 100 delegates together to accelerate desperately needed research into Ewing sarcoma 👉 ow.ly/pmnX50LFONK #Research #UntilTheresACure

The @TexasChildrens O'Quinn Medical Tower and the fountains at Texas Children's Hospital West Campus and The Woodlands were lit up gold in recognition of #ChildhoodCancerAwarenessMonth! Join us in raising awareness during the month of September

🔬Dr. Jason Yustein discussed his research - evaluating combination therapies to improve immune-mediated approaches for osteosarcoma. 💬Watch the full episode here or listen where you podcast! youtu.be/T_0vTzLySu4 ✨This episode is sponsored by our friends at @osinstitute.

🔊Today we share #Review "Recent Insights into Therapy Resistance in #Osteosarcoma" 👏by @ZPrudowskyMD and Jason T. Yustein @YusteinLab @bcmhouston @TexasChildrens Access the paper here👉mdpi.com/2072-6694/13/1… Keywords: osteosarcoma; chemotherapy resistance

@AgentsMIB @CUSystem @ChildrensColo @ColoradoStateU @EmoryUniversity Grateful and honored! 🎗 Thanks @AgentsMIB

🔬The Outsmarting Osteosarcoma Award, $100,000 each: 🔹Michael Leibowitz, MD, PhD | @CUSystem / @ChildrensColo 🔹Dan Regan, DVM, PhD | @ColoradoStateU 🔹Jason Yustein, MD, PhD | @EmoryUniversity

👏MIB Agents is awarding six OutSmarting Osteosarcoma grants totaling $450,000 in 2022! 📰For the full press release on these exciting awards and FACTOR: prn.to/3tIsJyb #outsmartingosteosarcoma #osteosarcoma #osteosarcomaresearchgrant #researchgrant #becauseofyou

New Research: Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications: Osteosarcoma is a primary malignant tumor that tends to threaten children and adolescents, and the 5-year event-free survival… frontiersin.org/articles/10.33… #immunology

😁FACTOR22PANEL: Liquid Biopsies & Biomarkers 👉Discussing what we can learn from osteosarcoma blood & tissue samples including best practices for optimizing & allocating tissue samples, & the latest on liquid biopsies for osteosarcoma. mibagents.org/factor22

John’s journey with Ewing's Sarcoma began with back pain, and tingling and numbness in his leg. He went through grueling treatment; unfortunately, John’s passed away on June 8th, 2019. His family established the John Phillip Douglass Fund. Story/donate : reininsarcoma.org/sarcoma-story-…

#EditorsChoice from our RAS pathway special issue is @YusteinLab's paper characterising advanced 🐁 model of paediatric #sarcoma that can enable development of novel therapies Chosen by guest Editors @DarArvin @bradylabupenn 💡journals.biologists.com/dmm/article/15… 📰journals.biologists.com/dmm/article/15…

Happy to share our new publication on RMS! K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications journals.biologists.com/dmm/article/15…

Celebrating Faris’ birthday and the 3-year anniversary of the Faris Foundation today!

OMG! The Faris Foundation Turns 3! - mailchi.mp/4247b9814c5c/f…